Frits Hess
Radboud University Nijmegen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Frits Hess.
European Journal of Vascular Surgery | 1993
Frits Hess; Suzanne Steeghs; R. Jerusalem; O. Reijnders; C. Jerusalem; B. Braun; P. Grande
A cell culture line was established from enzymatically-derived canine jugular endothelial cells and further cultured. Whenever sufficient cells were present, fibrous polyurethane vascular prostheses, impregnated with gelatin and coated with fibronectin, were seeded with 4.8 x 10(5)/cm2 cells, sufficient to establish a confluent monolayer, and implanted in the femoral arteries of 16 dogs. A non-seeded prosthesis on the contralateral side served as control. Eight dogs received antiplatelet aggregation medication: 250 mg aspirin together with 25 mg dipyridamole, orally three times daily, starting 2 weeks prior to the implantation operation and continued for the duration of the experiment. Results show that in the non-medicated dogs all control prostheses become occluded within 3 weeks after implantation, whereas five out of eight seeded prostheses remained patent. In the medicated group, two out of eight control prostheses occluded and all seeded prostheses remained patent. Scanning and light microscopy revealed that seeded prostheses were completely lined with endothelial cells (Factor VIII positive stain) week 3 (n = 3) and 12 (n = 3) after implantation, while endothelialisation in control prostheses had advanced only 5 mm into the prostheses in 12 weeks. Two dogs of each group were included in long-term patency studies. We conclude that prostheses seeded with a confluent monolayer of endothelial cells result in superior patency rates for both medicated and non-medicated dogs. No immunological reaction against the (allogeneic) seeded endothelial cells were noted.
Journal of Hepatology | 1989
Peter L. M. Jansen; Frits Hess; Wilbert H.M. Peters; Emile B. Koenders; C. Jerusalem; Frans H.M. Corstens
In this study auxiliary liver transplantation (ALT) has been tested as a means of correcting the UDP-glucuronyltransferase deficiency in Gunn rats and the UDP-glucuronyltransferase deficiency and impaired hepatobiliary bilirubin transport in double mutant rats. In both groups serum bilirubin normalized and remained low until the end of the study at 12 weeks after transplantation in 4 out of 6 rats. Excretion of 99mTc-HIDA in non-transplanted double mutants was considerably slower than in Gunn rats (kel 0.9 x 10(-3) versus 4.3 x 10(-3) s-1). HIDA excretion by transplants in double mutants and Gunn rats was about equal (kel 1.6 x 10(-3) and 1.1 x 10(-3) s-1). Experiments with bile duct-cannulated transplants showed that in double mutants bile flow, bile acid and bilirubin excretion was 2-4 times higher than in Gunn rats. This study shows that auxiliary liver transplants can conjugate and excrete bilirubin when one of these or both functions are lacking in the recipients liver.
Archives of Surgery | 1972
Frits Hess; C. Jerusalem; M. Niels van der Heyde
Microsurgery | 1985
Frits Hess
Journal of Biomedical Materials Research | 1984
Frits Hess; C. Jerusalem; P. Grande; B. Braun
Microsurgery | 1985
Frits Hess; C. Jerusalem; Bernd Braun; P. Grande
Microsurgery | 1983
Frits Hess; C. Jerusalem; Bernd Braun; P. Grande
Microsurgery | 1989
Frits Hess; Suzanne Steeghs; C. Jerusalem
Microsurgery | 1986
Frits Hess; C. Jerusalem; Bernd Braun; P. Grande
Microsurgery | 1991
Frits Hess; Suzanne Steeghs; C. Jerusalem; Bernd Braun; P. Grande